These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 15183239
1. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. Jung R, Fish DN, Obritsch MD, MacLaren R. J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239 [Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. Raja NS, Singh NN. J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906 [Abstract] [Full Text] [Related]
3. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Obritsch MD, Fish DN, MacLaren R, Jung R. Antimicrob Agents Chemother; 2004 Dec; 48(12):4606-10. PubMed ID: 15561832 [Abstract] [Full Text] [Related]
4. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006). Yoo J, Sohn ES, Chung GT, Lee EH, Lee KR, Park YK, Lee YS. Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936 [Abstract] [Full Text] [Related]
5. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005. Babay HA. Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646 [Abstract] [Full Text] [Related]
6. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa. Al-Jasser AM, Elkhizzi NA. Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211 [Abstract] [Full Text] [Related]
7. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Master RN, Clark RB, Karlowsky JA, Ramirez J, Bordon JM. Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249 [Abstract] [Full Text] [Related]
8. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]. Zarakolu P, Hasçelik G, Unal S. Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842 [Abstract] [Full Text] [Related]
9. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H. Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [Abstract] [Full Text] [Related]
10. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN. Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827 [Abstract] [Full Text] [Related]
11. Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey. Işeri L, Bayraktar MR. New Microbiol; 2008 Jul; 31(3):351-5. PubMed ID: 18843889 [Abstract] [Full Text] [Related]
12. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units. Georges B, Conil JM, Dubouix A, Archambaud M, Bonnet E, Saivin S, Lauwers-Cancès V, Cristini C, Cougot P, Decun JF, Mathe O, Chabanon G, Marty N, Seguin T, Houin G. Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152 [Abstract] [Full Text] [Related]
13. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin. Drago L, De Vecchi E, Nicola L, Tocalli L, Gismondo MR. J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767 [Abstract] [Full Text] [Related]
14. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units. Pierson CL, Friedman BA. Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439 [Abstract] [Full Text] [Related]
15. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [Abstract] [Full Text] [Related]
16. [Evaluation of resistance of Pseudomonas aeruginosa isolates to select antibiotics]. Sekowska A, Janicka G, Wojda M, Wróblewska J, Manysiak S. Pol Merkur Lekarski; 2005 Aug; 19(110):169-71. PubMed ID: 16245425 [Abstract] [Full Text] [Related]
17. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa. Lister PD, Wolter DJ. Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098 [Abstract] [Full Text] [Related]
18. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002. Mohr JF, Jones A, Ostrosky-Zeichner L, Wanger A, Tillotson G. Int J Antimicrob Agents; 2004 Oct 15; 24(4):346-51. PubMed ID: 15380259 [Abstract] [Full Text] [Related]
19. [Surveillance of multidrug resistant bacteria in a Tunisian hospital]. Thabet L, Messadi Aa, Mbarek M, Turki A, Meddeb B, Ben Redjeb S. Tunis Med; 2008 Nov 15; 86(11):992-5. PubMed ID: 19213491 [Abstract] [Full Text] [Related]
20. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan. Leung CH, Wang NY, Liu CP, Weng LC, Hsieh FC, Lee CM. J Microbiol Immunol Infect; 2008 Dec 15; 41(6):491-8. PubMed ID: 19255693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]